ArticleOncotarget2014

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Zenobia C D'Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.